Market Overview:
The global automated cell culture market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market is segmented by type, application, and region. The type segment is divided into model system, integrated system, and others (including semi-automated and manual systems). The integrated system occupied the majority of market share of 60%, while model system had a market share of 40%. By application, the academic & research institutes segment accounted for the largest share in 2017 and is projected to grow at a CAGR of 8.0% during the forecast period.
Product Definition:
Automated Cell Culture is the use of machines to perform tasks related to cell culture, such as handling and dispensing cells and media. Automated Cell Culture allows for more reproducible results, as well as increased throughput.
Model System:
Models are systems that can be used to represent or mimic aspects of the cell culture and its microenvironment. The most commonly used model systems are insect, yeast, mammalian and bacterial. These models have been widely adopted by researchers for various applications such as drug discovery & development, toxicity testing etc.
The advantages of using model system in vitro cell culture include it's cost-effective nature (no need for expensive equipment), easy availability of raw materials (such as nutrients).
Integrated System:
Integrated system and it's usage in automated cell culture is a new technology that has been developed to overcome the limitations of traditional systems. The integrated system provides many advantages over conventional techniques such as high throughput, automation, and integration with analytical tools. This technology has been used for various applications such as drug discovery & development, bioprocessing engineering & analysis, clinical diagnostics research etc.
Application Insights:
Based on application, the market is segmented into academic and research institutes, biopharmaceutical companies and others. The academic and research institutes segment dominated the market in 2017 owing to increasing government funding for stem cell research coupled with an increase in number of R&D centers across the globe. This has led to increased demand for automated cell culture systems among other applications within this sector.
The biopharmaceutical companies segment is expected to witness lucrative growth over the forecast period due to high demand from various drug discovery projects as well as clinical trials involving these systems. Increasing R&D activities pertaining to new therapeutic areas have also supported this growth along with a rise in number of approvals by regulatory authorities such as FDA (U.S.) & EMA (Europe).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of industry players, continuous technological advancements and high adoption rate for automated cell culture systems among academic & research institutes and biopharmaceutical companies. The U.S.-based companies are involved in extensive R&D activities to develop advanced automated cell culture systems that comply with cGMP guidelines for drug development process.
Asia Pacific is expected to grow at a lucrative CAGR over the forecast period owing to increasing investments by international market players as well as government support for developing healthcare infrastructure in emerging countries such as China, India, Singapore and South Korea etc.). In addition, rising awareness about stem cells usage will drive this regional market further on account of growing demand from clinical applications such as regenerative medicine & tissue engineering which has led major pharmaceutical companies including Pfizer Inc., Novartis AG., Merck KGaA etc.
Growth Factors:
- Increasing demand for biopharmaceuticals: The global market for biopharmaceuticals is expected to reach 2.8 billion by 2020, according to a MarketsandMarkets research study. This growth is being driven by the increasing prevalence of chronic diseases, such as cancer and diabetes, and the need for better treatments.
- Advances in cell culture technology: Automated cell culture systems are becoming increasingly sophisticated, with features that allow researchers to more easily control the environment in which cells are grown. This allows for more precise experimentation and faster development of new therapies.
- Growing focus on regenerative medicine: Regenerative medicine is an area of growing interest among researchers and investors, as it holds potential for treating a wide range of diseases and conditions. Regenerative medicine therapies often require large numbers of cultured cells, making automated systems well-suited for this application area.
Scope Of The Report
Report Attributes
Report Details
Report Title
Automated Cell Culture Market Research Report
By Type
Model System, Integrated System, Integrated System occupied the majority of market share of 60%, while Model system had a market share of 40%
By Application
Academic & Research Institutes, Biopharma Companies
By Companies
Danaher, Sartorius, GE, Tecan, Agilent, SHIBUYA, Hamilton Company, Merck KGaA, Lonza, Kawasaki, Biospherix, Cell Culture Company, Aglaris, Icomes Lab
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Automated Cell Culture Market Report Segments:
The global Automated Cell Culture market is segmented on the basis of:
Types
Model System, Integrated System, Integrated System occupied the majority of market share of 60%, while Model system had a market share of 40%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic & Research Institutes, Biopharma Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Danaher
- Sartorius
- GE
- Tecan
- Agilent
- SHIBUYA
- Hamilton Company
- Merck KGaA
- Lonza
- Kawasaki
- Biospherix
- Cell Culture Company
- Aglaris
- Icomes Lab
Highlights of The Automated Cell Culture Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Model System
- Integrated System
- Integrated System occupied the majority of market share of 60%, while Model system had a market share of 40%
- By Application:
- Academic & Research Institutes
- Biopharma Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Automated Cell Culture Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Automated cell culture is a process that allows scientists to grow cells in a controlled environment. This process helps researchers study the behavior and growth of cells in an isolated and reproducible setting.
Some of the major companies in the automated cell culture market are Danaher, Sartorius, GE, Tecan, Agilent, SHIBUYA, Hamilton Company, Merck KGaA, Lonza, Kawasaki, Biospherix, Cell Culture Company, Aglaris, Icomes Lab.
The automated cell culture market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Automated Cell Culture Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Automated Cell Culture Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Automated Cell Culture Market - Supply Chain
4.5. Global Automated Cell Culture Market Forecast
4.5.1. Automated Cell Culture Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Automated Cell Culture Market Size (000 Units) and Y-o-Y Growth
4.5.3. Automated Cell Culture Market Absolute $ Opportunity
5. Global Automated Cell Culture Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Automated Cell Culture Market Size and Volume Forecast by Type
5.3.1. Model System
5.3.2. Integrated System
5.3.3. Integrated System occupied the majority of market share of 60%, while Model system had a market share of 40%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Automated Cell Culture Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Automated Cell Culture Market Size and Volume Forecast by Application
6.3.1. Academic & Research Institutes
6.3.2. Biopharma Companies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Automated Cell Culture Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Automated Cell Culture Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Automated Cell Culture Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Automated Cell Culture Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Automated Cell Culture Demand Share Forecast, 2019-2026
9. North America Automated Cell Culture Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Automated Cell Culture Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Automated Cell Culture Market Size and Volume Forecast by Application
9.4.1. Academic & Research Institutes
9.4.2. Biopharma Companies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Automated Cell Culture Market Size and Volume Forecast by Type
9.7.1. Model System
9.7.2. Integrated System
9.7.3. Integrated System occupied the majority of market share of 60%, while Model system had a market share of 40%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Automated Cell Culture Demand Share Forecast, 2019-2026
10. Latin America Automated Cell Culture Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Automated Cell Culture Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Automated Cell Culture Market Size and Volume Forecast by Application
10.4.1. Academic & Research Institutes
10.4.2. Biopharma Companies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Automated Cell Culture Market Size and Volume Forecast by Type
10.7.1. Model System
10.7.2. Integrated System
10.7.3. Integrated System occupied the majority of market share of 60%, while Model system had a market share of 40%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Automated Cell Culture Demand Share Forecast, 2019-2026
11. Europe Automated Cell Culture Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Automated Cell Culture Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Automated Cell Culture Market Size and Volume Forecast by Application
11.4.1. Academic & Research Institutes
11.4.2. Biopharma Companies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Automated Cell Culture Market Size and Volume Forecast by Type
11.7.1. Model System
11.7.2. Integrated System
11.7.3. Integrated System occupied the majority of market shar of 60%, while Model system had a market share of 40%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Automated Cell Culture Demand Share, 2019-2026
12. Asia Pacific Automated Cell Culture Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Automated Cell Culture Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Automated Cell Culture Market Size and Volume Forecast by Application
12.4.1. Academic & Research Institutes
12.4.2. Biopharma Companies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Automated Cell Culture Market Size and Volume Forecast by Type
12.7.1. Model System
12.7.2. Integrated System
12.7.3. Integrated System occupied the majority of market share of 60%, while Model system had a market share of 40%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Automated Cell Culture Demand Share, 2019-2026
13. Middle East & Africa Automated Cell Culture Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Automated Cell Culture Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Automated Cell Culture Market Size and Volume Forecast by Application
13.4.1. Academic & Research Institutes
13.4.2. Biopharma Companies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Automated Cell Culture Market Size and Volume Forecast by Type
13.7.1. Model System
13.7.2. Integrated System
13.7.3. Integrated System occupied the majority of market share of 60%, while Model system had a market share of 40%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Automated Cell Culture Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Automated Cell Culture Market: Market Share Analysis
14.2. Automated Cell Culture Distributors and Customers
14.3. Automated Cell Culture Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Danaher
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sartorius
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GE
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Tecan
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Agilent
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. SHIBUYA
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hamilton Company
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Merck KGaA
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Lonza
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Kawasaki
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Biospherix
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Cell Culture Company
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Aglaris
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Icomes Lab
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
